The comparative effects of haloperidol, (-)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity

European Neuropsychopharmacology

Volumn 7, Issue 3, 1997, Pages 181-187

  Ozaki, T ^a   Katsumoto, E ^a   Yokotani, N ^a   Yamagami, S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AP 1; c fos; c jun; Dopamine D2 receptor; mRNA; Neuroleptics

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DNA; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; NUCLEAR PROTEIN; SULPIRIDE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DENSITOMETRY; DOSE RESPONSE; DRUG RECEPTOR BINDING; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; SCHIZOPHRENIA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; DNA; DOPAMINE ANTAGONISTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HALOPERIDOL; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED STRAINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RIBONUCLEASES; RNA PROBES; RNA, MESSENGER; SULPIRIDE; TRANSCRIPTION FACTOR AP-1;

EID: 0030926377     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00397-0     Document Type: Article

References (30)

1. Angel, P., Hattori, K., Smeal, T. and Karin, M. (1988) The jun proto-oncogene is positively autoregulated by its products, Jun/AP-1. Cell 55, 875-885.
2. Angulo, J.A., Cadet J.L., Woolley, C.S., Suber, F. and McEwen, B.S. (1990) Effects of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat. J. Neurochem. 54, 1889-1894.
3. Aronin, N., Chase, K., Sagar, S.M., Sharp, F.R. and Difiglia, M. (1991) N-Methyl-D-aspartate receptors activation in the neostriatum increases c-fos and fos-related antigens selectively in medium sized neurons. Neuroscience 44, 409-420.
4. Bannon M.J., Reinhard Jr., J.F. and Bunney E.B. (1982) Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurons. Nature 296, 444-446.
5. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol -chloroform extraction. Anal. Biochem. 162, 156-159.
6. Cuhin, R., Angel, P. and Karin, M. (1989) JunB differs in its biological properties form and is a negative regulator of c-jun. Cell 59, 979-986.
7. Dragunow, M., Robertson, G.S., Faull, R.Z.M., Robertson, H.A. and Jansen, K. (1990) D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37, 287-294.
8. Graybiel, A.M., Moratalla, R. and Robertson, H.A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87, 6912-6916.
9. Gubits, R.M., Smith, T.M., Fairhurst, J.L. and Yu, H. (1989) Adrenergic receptors mediate changes in c-fos mRNA levels in brain. Mol. Brain Res. 6(1), 39-45.
10. Kaczmarele, L., Siedlecki, J.A. and Danysz, W. (1988) Proto-oncogene c-fos induction in rat hippocampus. Mol. Brain Res. 3, 183-186.
11. Kouzarides, T. and Ziff, E. (1988) The role of the leucine zipper in the fos-jun interaction. Nature 336, 646-651.
12. Lee, W., Mitchell, P. and Tjian, R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752.
13. Morgan J.I. and Curran T. (1989) Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 12, 459-462.
14. Nakabeppu, Y. and Nathans, D. (1991) A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64, 751-759.
15. Nguyen, T.V., Kosofsky, B.E., Birubaum, R., Cohen, B.M. and Hyman, S.E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine and amphetamine. Proc. Natl. Acad. Sci. USA 89, 4270-4274.
16. Ozaki, T., Yokotani, N., Katsumoto, E., Onishi, H. and Yamagami, S. (1994) The difference among effects of haloperidol, (-)-sulpiride and SCH23390 on the expression of c-fos and c-jun mRNA induction. Eur. Neuropsychopharmacol. 4, 365.
17. Ozaki, T., Katsumoto, E., Yokotani, N. and Yamagami, S. (1995) The effect of neuroleptics on the AP-1 DNA binding activity and the induction of fos and jun. Eur. Neuropsychopharmacol. 5, pp. 328.
18. Rauscher, F.J., III, Sambucetti, L.C., Curran, T., Distel, R.J. and Spiegelman, B.M. (1988a) Common DNA binding site for Fos protein complexes and transcription factor AP-1. Cell 52, 471-480.
19. Reader, T.A., Molina-Holgand, E. and Dewar, K.M. (1992) Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors. Mol. Neurobiol. 6, 425-450.
20. Robertson, G.S. and Fibiger, H.C. (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46, 315-328.
21. Robertson, G.S., Vincent, S.R. and Fibiger, H.C. (1992) D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49, 285-296.
22. Saitoh, Y., Silverman, A.J. and Gibson, M.J. (1991) Norepinephrine neurons in mouse locus coerulens express c-fos protein after N-methyl-D,L-aspartic acid (NMDA) treatment: relation to LH release. Brain Res. 561, 11-19.
23. Sambucetti L.C. and Curran T. (1986) The fos protein is associated with DNA in isolated nuclei and binds to DNA cellulose. Science 234, 1417-1419.
24. Sassone-Corci, P., Sisson, J.C. and Verna, I. (1988) Transcriptional autoregulation of the proto-oncogene fos. Nature 334, 319-329.
25. Schreiber E., Matthias P., Muller M.M. and Schaffner W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
26. Seeman, P., Lee, T., Chang-Wong, M. and Wong, K. (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261, 717.
27. Sonnenberg, J.L., Mitchelmore, C., Macgregor-Leon, P.F., Hempstead, J., Morgan, J.I. and Curran, T. (1989) Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24, 72-80.
28. Sonnenberg, J.L., Rauscher, F.L. III., Morgen, J.I. et al. (1990) Regulation of proenkephaline by Fos and Jun. Science 246, 1622-1625.
29. Van Beveren, C., Van Straaten, F., Curran, T., Muller, R. and Verma, I.M. (1983) Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 32, 1241-1255.
30. Zinn, K., DiMaio, D. and Maniatis, T. (1983) Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell 34, 865-879.